Arcturus Therapeutics Holdings (ARCT) said Tuesday it has appointed Moncef Slaoui as chair designate.
Slaoui has been a member of the company's board since June 2024 and most recently served as chief scientific advisor to the White House's Operation Warp Speed, according to Arcturus.
Price: 15.73, Change: -0.07, Percent Change: -0.44